LCE 75 (Carbidopa, Entacapone and Levodopa 18.75 mg / 200 mg / 75 mg)
Pill with imprint LCE 75 is Red, Elliptical / Oval and has been identified as Carbidopa, Entacapone and Levodopa 18.75 mg / 200 mg / 75 mg. It is supplied by Sandoz Inc.
Carbidopa/entacapone/levodopa is used in the treatment of parkinson's disease and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Carbidopa/entacapone/levodopa 18.75 mg / 200 mg / 75 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for LCE 75
Carbidopa, Entacapone and Levodopa
- Imprint
- LCE 75
- Strength
- 18.75 mg / 200 mg / 75 mg
- Color
- Red
- Shape
- Elliptical / Oval
- Availability
- Prescription only
- Drug Class
- Dopaminergic antiparkinsonism agents
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Sandoz Inc
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00781-5625 | Sandoz Inc. |
| 00078-0544 | Novartis Pharmaceuticals Corporation |
Related Images for "LCE 75"
More about carbidopa / entacapone / levodopa
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 8 Reviews
- Drug class: dopaminergic antiparkinsonism agents
- FDA Alerts (3)
Consumer resources
- Patient Information
- Carbidopa, entacapone, and levodopa (Advanced Reading)
- Levodopa, Carbidopa, and Entacapone
- Other brands
- Stalevo, Stalevo 100, Stalevo 200, Stalevo 125, ... +3 more
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.